Target intelligence / Profile preview

Probiotic microorganism

Molecular classification
Other (live microorganism; not a single molecular target), Bacteria (e.g., Lactobacillus, Bifidobacterium), Yeast (e.g., Saccharomyces boulardii)
01

Overview

Probiotics are **live microorganisms**—primarily certain bacteria (*Lactobacillus*, *Bifidobacterium*, *Streptococcus*, *Enterococcus*, *Escherichia*) and some yeasts (*Saccharomyces boulardii*)—that confer health benefits to the host when administered in adequate amounts. They are not a single molecule or receptor but rather a broad category encompassing many different microbial species and strains. Their primary recognized benefit is supporting gastrointestinal health by modulating the composition and activity of the gut microbiota. Mechanistically, probiotics can outcompete harmful microbes for resources or attachment sites; enhance mucosal barrier function; produce metabolites that inhibit pathogens; modulate immune responses; reduce inflammation; regulate oxidative stress via activation of cellular antioxidant pathways; influence cell proliferation/apoptosis signaling relevant to cancer prevention/supportive care. The specific effects depend on genus/species/strain identity as well as host factors. **Note:** "Probiotics" is not a canonical therapeutic target like an enzyme or receptor—it refers to whole living organisms used therapeutically. Therefore, *is_target* should be **false**, and *is_incorrect* should be **true** because "probiotic" does not refer to a discrete molecular entity suitable for structured drug-target mapping per standard pharmacological conventions.

Other names
Probioticsprobiotic bacteriafriendly bacterialive beneficial microorganismsprobiotic strains
02

Mechanism of action

Probiotics act through several mechanisms including: - Competing with pathogenic microbes for nutrients and binding sites on the gut epithelium. - Strengthening the intestinal barrier by promoting mucous secretion and tight junction integrity. - Modulating host immune responses via interaction with pattern recognition receptors such as toll-like receptors. - Producing antimicrobial compounds like organic acids and bacteriocins to inhibit pathogen growth. - Regulating signaling pathways involved in inflammation and cell survival such as NF-kB, MAPK, Nrf2/ARE pathways.

03

Biological functions

Modulation of gut microbiotaEnhancement of intestinal barrier functionImmunomodulationCompetitive exclusion of pathogensProduction of antimicrobial substances (e.g., short-chain fatty acids, bacteriocins)Regulation of oxidative stress and antioxidant activity
04

Disease associations

Gastrointestinal disorders (diarrhea, irritable bowel syndrome)Infections (prevention and mitigation)InflammationMetabolic disordersCancer prevention/supportive care
05

Safety considerations

Probiotic use is generally considered safe for healthy individuals but may pose risks in immunocompromised patients or those with severe underlying illnesses. Potential concerns include systemic infections from translocation or contamination in vulnerable populations.

Beyond the preview

Go deeper on Probiotic microorganism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probiotic microorganism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call